Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nancy G. Houlihan"'
Autor:
Nancy G. Houlihan
Publikováno v:
Oncology nursing forum. 42(5)
The term rare cancers is relatively new in oncology, with significant presence in cancer literature occurring only since the early 2000s. Epidemiologic studies in Europe and the United States show that rare cancers account for about 25% of adult canc
Autor:
Nancy G. Houlihan
Publikováno v:
Oncology nursing forum. 42(2)
Publikováno v:
Clinical Journal of Oncology Nursing. 8:645-652
Autor:
Nancy G. Houlihan
Publikováno v:
Oncology Nursing Forum. 42:423-424
Autor:
Nancy G. Houlihan
Publikováno v:
Oncology Nursing Forum. 42:319-320
The December 2014 issue of the European Journal of Oncology Nursing published an article by Näppä, Rasmussen, Axelsson, and Lindqvist that reported on a qualitative study of the challenges experienced by Swedish nurses when administering palliative
Autor:
Nancy G. Houlihan, Mary S. McCabe
Publikováno v:
Oxford Textbook of Palliative Nursing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b39cf1d7f19e907c761f0219a101c51e
https://doi.org/10.1093/med/9780195391343.003.0044
https://doi.org/10.1093/med/9780195391343.003.0044
Autor:
Nancy G, Houlihan
Publikováno v:
Oncology (Williston Park, N.Y.). 23
Survivorship care plans have received increasing attention since the 2006 release of the Institute of Medicine report, From Cancer Patient to Cancer Survivor: Lost in Transition. The report strongly recommends that at completion of cancer treatment,
Autor:
Nancy G. Houlihan, Leslie B. Tyson
Publikováno v:
Seminars in oncology nursing. 24(1)
Autor:
Nancy G. Houlihan
Publikováno v:
Oncology Nursing Forum. 42:695-695
Chemotherapy exposure during drug administration and provision of care is a known risk for oncology nurses and other healthcare workers. Guidelines to minimize exposure to hazardous drugs, such as chemotherapy, have long been in place to decrease pot
Autor:
Nancy G. Houlihan, Deanna M. Xistris
Publikováno v:
Seminars in oncology nursing. 10(4)
Changes in reimbursement and health care reform permeate all practice settings of oncology care today. Chemotherapy and biologic regimens used in cancer therapy are easy targets for reimbursement denials because of regulations against their investiga